These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31486200)

  • 1. Toxic epidermal necrolysis associated with ribociclib in a patient with metastatic breast cancer.
    Bozkaya Y; Ay B
    Breast J; 2020 Apr; 26(4):773-774. PubMed ID: 31486200
    [No Abstract]   [Full Text] [Related]  

  • 2. Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients.
    Rascon K; Flajc G; De Angelis C; Liu X; Trivedi MV; Ekinci E
    Ann Pharmacother; 2019 May; 53(5):501-509. PubMed ID: 30522347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribociclib for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer.
    Burris HA
    Expert Rev Anticancer Ther; 2018 Mar; 18(3):201-213. PubMed ID: 29457921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Cardiotoxicity of Palbociclib and Ribociclib in Breast Cancer: Gene Expression and Pharmacological Data Analyses, Biological Basis, and Therapeutic Implications.
    Santoni M; Occhipinti G; Romagnoli E; Miccini F; Scoccia L; Giulietti M; Principato G; Saladino T; Piva F; Battelli N
    BioDrugs; 2019 Dec; 33(6):613-620. PubMed ID: 31529317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3.
    Slamon DJ; Neven P; Chia S; Fasching PA; De Laurentiis M; Im SA; Petrakova K; Bianchi GV; Esteva FJ; Martín M; Nusch A; Sonke GS; De la Cruz-Merino L; Beck JT; Pivot X; Vidam G; Wang Y; Rodriguez Lorenc K; Miller M; Taran T; Jerusalem G
    J Clin Oncol; 2018 Aug; 36(24):2465-2472. PubMed ID: 29860922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic epidermal necrolysis in patient with breast cancer receiving letrozole.
    Chia WK; Lim YL; Greaves MW; Ang P
    Lancet Oncol; 2006 Feb; 7(2):184-5. PubMed ID: 16455483
    [No Abstract]   [Full Text] [Related]  

  • 10. Ribociclib (Kisqali) for advanced or metastatic breast cancer.
    Med Lett Drugs Ther; 2017 Oct; 59(1532):e178-e179. PubMed ID: 29039822
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic drug evaluation of ribociclib for the treatment of metastatic, hormone-positive breast cancer.
    Curigliano G; Criscitiello C; Esposito A; Intra M; Minucci S
    Expert Opin Drug Metab Toxicol; 2017 May; 13(5):575-581. PubMed ID: 28395543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribociclib Causing Transient Glanzmann Thrombasthenia-like Picture: A Report of 4 Cases.
    Awidi AS; Bawa'neh HS; Al-Showbaki LN; Alqaisi HA; Awidi MA; Khalil LT; El Khatib OH; Mansour AT
    Clin Breast Cancer; 2019 Oct; 19(5):e593-e595. PubMed ID: 31311720
    [No Abstract]   [Full Text] [Related]  

  • 13. Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
    Im SA; Lu YS; Bardia A; Harbeck N; Colleoni M; Franke F; Chow L; Sohn J; Lee KS; Campos-Gomez S; Villanueva-Vazquez R; Jung KH; Chakravartty A; Hughes G; Gounaris I; Rodriguez-Lorenc K; Taran T; Hurvitz S; Tripathy D
    N Engl J Med; 2019 Jul; 381(4):307-316. PubMed ID: 31166679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity associated with ribociclib among breast cancer patients.
    Finnsdottir S; Sverrisdottir A; Björnsson ES
    Acta Oncol; 2021 Feb; 60(2):195-198. PubMed ID: 33272079
    [No Abstract]   [Full Text] [Related]  

  • 17. Ribociclib Lengthens Breast Cancer Survival.
    Cancer Discov; 2016 Dec; 6(12):1299. PubMed ID: 27810861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
    van der Meer JB
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxic epidermal necrolysis with the use of tamoxifen.
    Madabhavi I; Revannasiddaiah S; Patel A; Anand A
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25878231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.